|
1
|
Gleason BC and Hornick JL: Inflammatory
myofibroblastic tumours: where are we now? J Clin Pathol.
61:428–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coffin CM and Fletcher JA: Inflammatory
myofibroblastic tumor. Fletcher CD, Unni KK and Mertens F; World
Health Organization Classification of Tumors: Pathology and
Genetics of Soft Tissue and Bone. IARC Press; Lyon: pp. 91–93.
2002
|
|
3
|
Coffin CM, Hornick JL and Fletcher CD;
Inflammatory myoblastic tumor: Comparison of clinicopathologic,
histologic, and immunohistochemical features including ALK
expression in atypical and aggressive cases. Am J Surg Pathol.
31:509–520. 2007.PubMed/NCBI
|
|
4
|
Kovach SJ, Fischer AC, Katzman PJ, Salloum
RM, Ettinghausen SE, Madeb R and Koniaris LG: Inflammatory
myofibroblastic tumors. J Surg Oncol. 94:385–391. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coffin CM, Watterson J, Priest JR and
Dehner LP: Extrapulmonary inflammatory myofibroblastic tumor
(inflammatory pseudotumor). A clinicopathologic and
immunohistochemical study of 84 cases. Am J Surg Pathol.
19:859–872. 1995. View Article : Google Scholar
|
|
6
|
Lee MH, Lee HB, Lee YC, Rhee YK, Lee EJ,
Chung MJ, Jin GY, Kweon EY and Park SJ: Bilateral multiple
inflammatory myofibroblastic tumors of the lung successfully
treated with corticosteroids. Lung. 189:433–435. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carswell C and Chataway J: The successful
long-term management of an intracranial inflammatory myoblastic
tumor with corticosteroids. Clin Neurol Neurosurg. 114:77–79. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hakozaki Y, Katou M, Nakagawa K, Shirahama
T and Matsumoto T: Improvement of inflammatory pseudotumor of the
liver after nonsteroidal anti-inflammatory agent therapy. Am J
Gastroenterol. 88:1121–1122. 1993.PubMed/NCBI
|
|
9
|
Imperato JP, Folkman J, Sagerman RH and
Cassady JR: Treatment of plasma cell granuloma of the lung with
radiation therapy. A report of two cases and review of the
literature. Cancer. 57:2127–2129. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bertocchini A, Lo Zupone C, Callea F,
Gennari F, Serra A, Monti L and de Ville de Goyet J: Unresectable
multifocal omental and peritoneal inflammatory myofibroblastic
tumor in a child: revisiting the role of adjuvant therapy. J
Pediatr Surg. 46:e17–e21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Butrynski JE, D’Adamo DR, Hornick JL, Dal
Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ,
Ramaiya N, Kwak EL, Clark JW, Wilner KD, Christensen JG, Jänne PA,
Maki RG, Demetri GD and Shapiro GI: Crizotinib in ALK-rearranged
inflammatory myofibroblastic tumor. New Engl J Med. 363:1727–1733.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su W, Ko A, O’Connell TX and Applebaum H:
J Pediatr Surg. 35:1635–1637. 2000. View Article : Google Scholar
|
|
13
|
Chan PW, Omar KZ and Ramanujam TM:
Successful treatment of unresectable inflammatory pseudotumor of
the lung with COX-2 inhibitor. Pediatr Pulmonol. 36:167–169. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Przkora R, Bolder U, Schwartz S, Jauch KW,
Spes J, Andreeson R and Mackensen A: Regression of nonresectable
inflammatory myofibroblastic tumours after treatment with
nonsteroidal anti-inflammatory drugs. Eur J Clin Invest.
34:320–321. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Colakoglu O, Unsal B, Haciyanli M, Tunakan
M, Buyrac Z, Yorukoglu G, Yazicioglu N and Genc H: A successfully
managed inflammatory pseudotumor of liver without surgery: report
of a case. Acta Gastroenterol Belg. 68:382–384. 2005.PubMed/NCBI
|
|
16
|
Vassiliadis T, Vougiouklis N, Patsiaoura
K, Mpoumponaris A, Nikolaidis N, Giouleme O and Evgenidis N:
Inflammatory pseudotumor of the liver successfully treated with
nonsteroidal anti-inflammatory drugs: a challenge diagnosis for one
not so rare entity. Eur J Gastroenterol Hepatol. 19:1016–1020.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mattei P and Barnaby K: Rapid regression
of duodenal inflammatory myofibroblastic tumor after intravenous
ketorolac: case report and review of the literature. J Pediatr
Surg. 43:1196–1199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Colangelo M, Lisi G and Chiesa PL:
Pancreatic inflammatory myofibroblastic tumor (IMT). J Pediatr
Surg. 45:1074–1075. 2009.PubMed/NCBI
|
|
19
|
Liao Z, Mason K and Milas L:
Cyclo-oxygenase-2 and its inhibition in cancer. Drugs. 67:821–846.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masferrer JL, Leahy KM, Koki AT, Zweifel
BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and
Seibert K: Antiangiogenic and antitumor activities of
cyclooxygenase-2 inhibitors. Cancer Res. 60:1306–1311.
2000.PubMed/NCBI
|
|
21
|
Applebaum H, Kieran MW, Cripe TP, Coffin
C, Collins MH, Kaipainen A, Laforme A and Shamberger RC: The
rationale for nonsteroidal anti-inflammatory drug therapy for
inflammatory myofibroblastic tumors: a Children’s Oncology Group
Study. J Pediatr Surg. 40:999–1003. 2005.PubMed/NCBI
|
